Abstract
Objectives To study outcomes with voriconazole therapy in immunocompetent individuals following maximal safe endoscopic resection in invasive aspergillosis of the anterior skull base.
Design Retrospective study of patients with chronic invasive aspergillosis including symptomatology, extent of disease, and response to voriconazole following maximal safe resection in immunocompetent individuals.
Setting Tertiary care superspeciality referral center.
Participants Ten consecutive patients of invasive aspergillosis of anterior skull base managed over a period of 2 years.
Main Outcome Measures Symptom resolution with systemic voriconazole and radiologic evaluation following systemic antifungals as per predefined protocol.
Conclusions Maximal safe resection via transnasal endoscopic route followed by systemic antifungals provides excellent outcomes in invasive skull base aspergillosis.
Although liver and renal functions, besides visual acuity, need serial monitoring, voriconazole is well tolerated by our patients.
Keywords
invasive aspergillosis - skull base - immunocompetent - endoscopic resection - voriconazole - itraconazole
